文献速递免疫规划

猪繁殖与呼吸综合征减毒活疫苗鼻腔免疫途径评价

Evaluation of the intranasal route for porcine reproductive and respiratory disease modified-live virus vaccination.
PubMed 文献 · Vaccine · 2021-10-24

接种28天后以强毒US PRRSV分离株攻毒,结果显示各接种组在病毒血症、血清转阳和平均日增重上无差异,但两种鼻腔接种组攻毒时针对疫苗病毒的中和抗体水平显著更高。结论提示鼻腔途径可作为PRRSV免疫的替代选择。

要点

  • 鼻腔与肌肉接种在病毒血症、血清转阳及增重上表现相当。
  • 两种鼻腔装置接种组攻毒时针对疫苗病毒的中和抗体显著更高。
  • 鼻腔途径可能是PRRSV减毒活疫苗免疫的替代选择。

核心结论

  • 鼻腔与肌肉接种获得相当的疫苗应答,提示鼻腔途径可作为PRRSV免疫的替代选择。

研究设计与样本

  • 各接种组使用同一PRRSV减毒活疫苗但接种途径不同,接种28天后全部接种组与POS-CONTROL组以致病性US PRRSV分离株攻毒。
  • 定期采集血液与鼻拭子,攻毒后第10天(dpc)剖检评估肺脏肉眼与显微病变。

主要发现

  • 攻毒前多数接种猪已对PRRSV血清转阳。
  • POS-CONTROL组自dpc 7起发热、食欲不振等临床症状最明显。
  • 各接种组在PRRSV病毒血症、血清转阳或平均日增重上无差异。
  • IN-JET-VAC与IN-MAD-VAC组攻毒时针对疫苗病毒的中和抗体水平显著更高。

临床怎么用

  • 对需减少注射操作的猪群,可考虑以鼻腔装置接种PRRSV减毒活疫苗作为肌肉注射的替代。
  • 选择鼻腔接种时应关注装置类型,因其可能影响攻毒时的中和抗体水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In pigs, modified live virus (MLV) vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) are commonly used and administered by intramuscular (IM) injection. In contrast, PRRSV, as a primary respiratory pathogen, is mainly transmitted via the intranasal (IN) route. The objective of this study was to evaluate the efficacy of a commonly used commercial PRRSV MLV delivered IN compared to the IM route. METHODS: Fifty-four pigs were divided into five treatment groups. All vaccinated groups received the same MLV vaccine but administered via different routes. Group IN-JET-VAC was vaccinated with an automated high pressure prototype nasal jet device (IN-JET-VAC, n = 12), group IN-MAD-VAC was vaccinated with a mucosal atomization device (IN-MAD-VAC, n = 12), group IM-VAC was vaccinated intramuscularly (IM-VAC; n = 12) according to label instructions, while the NEG-CONTROL (n = 6) and the POS-CONTROL (n = 12) groups were both unvaccinated. At 28 days post vaccination all vaccinated groups and the POS-CONTROL pigs were challenged with a pathogenic US PRRSV isolate. Blood and nasal swabs were collected at regular intervals, and all pigs were necropsied at day 10 post challenge (dpc) when gross and microscopic lung lesions were assessed. RESULTS: Prior to challenge most vaccinated pigs had seroconverted to PRRSV. Clinical signs (fever, inappetence) were most obvious in the POS-CONTROL group from dpc 7 onwards. The vaccinated groups were not different for PRRSV viremia, seroconversion, or average daily weight gain. However, IN-JET-VAC and IN-MAD-VAC had significantly higher neutralizing antibody levels against the vaccine virus at challenge. CONCLUSIONS: Comparable vaccine responses were obtained in IN and IM vaccinated pigs, suggesting the intranasal administration route as an alternative option for PRRSV vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Opriessnig T, Rawal G, McKeen L, et al. Evaluation of the intranasal route for porcine reproductive and respiratory disease modified-live virus vaccination. Vaccine. 2021. PMID: 34706840. doi:10.1016/j.vaccine.2021.10.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。